Pharmaceuticals

Cadila Healthcare to demerge consumer products division into Carnation, merge Zydus Hospitals with itself

05 Jul 2008

UK's Shire acquires maker of Firazyr, Jerini AG

04 Jul 2008

US court ruling helps AstraZeneca stave off Teva, Sandoz from 4$-billion Seroquel

03 Jul 2008

A US court has upheld  Anglo-Swedish pharmaceutical group AstraZeneca's patent rights to the over $4 billion a year schizophrenia and bipolar blockbuster Seroquel

Piramal Healthcare acquires PlasmaSelect's polygeline product Haemaccel

03 Jul 2008

FDA bars use of Merck's cancer vaccine by women over 27

26 Jun 2008

Sun goes ahead with Taro acquisition; files suit in US court

26 Jun 2008

Tentative nod from USFDA for Ranbaxy's cancer drug valganciclovir

26 Jun 2008

Zentiva turns down PPF subsidiary Anthiarose as Sanofi makes rival bid

23 Jun 2008

Johnson & Johnson Nordic AB acquires Åmic

23 Jun 2008

Glenmark gets USFDA approval for anti-hypertensive, Trandolapril

20 Jun 2008

Daiichi to make open offer for Ranbaxy on August 8

16 Jun 2008

Japanese drug maker Daiichi Sankyo, which agreed to acquire Ranbaxy promoter group's 34.8 per cent stake in Ranbaxy Laboratories, will make an open offer for another 20 per cent in the Indian pharma major on August 8.

Natco Pharma grants global marketing for its generic Copaxone to Mylan

10 Jun 2008

Mylan Inc. acquires Merck KGaA's central eastern European generics businesses

02 Jun 2008

CuraGen presents encouraging results from ongoing Phase I / II study of CR011-vcMMAE in metastatic melanoma

02 Jun 2008

Glenmark gets nod for marketing two drugs in US

30 May 2008

Zydus Cadila acquires Spanish drug firm Laboratories Combix

30 May 2008

Israel's Taro to terminate merger with Sun Pharmaceutical

28 May 2008

Pharma firms threaten to stop production

28 May 2008

Over 650 drug manufacturers say they would halt production of several products within a month or two unless the government hike prices of 33 bulk drugs with immediate effect

Alnylam in $1 billion RNAi drug research deal with Japan's Takeda

28 May 2008

US biotech firm Alnylam Pharmaceuticals and Japan's Takeda Pharmaceutical will jointly develop drugs for treatment of cancer and metabolic diseases using RNAi technology, under a deal potentially valued at $1 billion.

Ranbaxy gets partial relief in `atorvastatin' case in Australia

28 May 2008

GVK BIO enters into drug discovery pact with Wyeth Pharmaceuticals

26 May 2008

Suven Life gets product patents in South Africa, China

20 May 2008

Zydus Cadila to market four products in the US after USFDA approval

16 May 2008

Ranbaxy to develop new drugs for Merck & Co

10 May 2008

Ranbaxy Laboratories, the country's largest drug maker is close to striking a deal for collaborating on research for new drug discovery with Merck.

Johnson & Johnson patent lawsuit agains Boston Scientific's NIR stent dismissed in Canada

09 May 2008